| Mrs Kaitlin Johnson, FNP | |
|
344 Great Rd, Acton, MA 01720-4004 | |
| (866) 389-2727 | |
| Not Available |
| Full Name | Mrs Kaitlin Johnson |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner |
| Experience | 11 Years |
| Location | 344 Great Rd, Acton, Massachusetts |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1053730853 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363LF0000X | Nurse Practitioner - Family | RN2290048 (Massachusetts) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Minuteclinic Diagnostic Of Massachusetts, Llc | 2264594944 | 120 |
News Archive
Standard treatment for prostate cancer can include chemotherapy that targets receptors on cancer cells. However, drug-resistant cancer cells can emerge during chemotherapy, limiting its effectiveness as a cancer-fighting agent. Researchers at the University of Missouri have proven that a compound initially developed as a cholesterol-fighting molecule not only halts the progression of prostate cancer, but also can kill cancerous cells.
In this digital age, where the internet accelerates technological development, there has been a surge of scientific innovation designed to improve the quality of life for patients in need.
Only one group of teenagers used marijuana more often after retail sales were legalized in Washington than they did before - high school seniors who work 11 or more hours per week, according to new research led by a WSU College of Nursing professor
"Having just returned to New York from Maputo, the capital of Mozambique, I'm reminded how lucky we are in this city to have reliable water and sanitation services," David Winder, chief executive of WaterAid USA, writes this post in Huffington Post's "Impact" blog.
Moffitt Cancer Center researchers developed a new way to identify possible therapeutic targets for patients with drug resistant melanoma. It involves using liquid chromatography-multiple reaction monitoring mass spectrometry to measure biomarkers or molecules in blood and tissue that indicates cancer is present. These measurements can help researchers determine if a patient is responding to treatment.
› Verified 2 days ago
| Entity Name | Minuteclinic Diagnostic Of Massachusetts, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1457470858 PECOS PAC ID: 2264594944 Enrollment ID: O20081215000803 |
News Archive
Standard treatment for prostate cancer can include chemotherapy that targets receptors on cancer cells. However, drug-resistant cancer cells can emerge during chemotherapy, limiting its effectiveness as a cancer-fighting agent. Researchers at the University of Missouri have proven that a compound initially developed as a cholesterol-fighting molecule not only halts the progression of prostate cancer, but also can kill cancerous cells.
In this digital age, where the internet accelerates technological development, there has been a surge of scientific innovation designed to improve the quality of life for patients in need.
Only one group of teenagers used marijuana more often after retail sales were legalized in Washington than they did before - high school seniors who work 11 or more hours per week, according to new research led by a WSU College of Nursing professor
"Having just returned to New York from Maputo, the capital of Mozambique, I'm reminded how lucky we are in this city to have reliable water and sanitation services," David Winder, chief executive of WaterAid USA, writes this post in Huffington Post's "Impact" blog.
Moffitt Cancer Center researchers developed a new way to identify possible therapeutic targets for patients with drug resistant melanoma. It involves using liquid chromatography-multiple reaction monitoring mass spectrometry to measure biomarkers or molecules in blood and tissue that indicates cancer is present. These measurements can help researchers determine if a patient is responding to treatment.
› Verified 2 days ago
| Entity Name | Minuteclinic Diagnostic Of Massachusetts, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1457470858 PECOS PAC ID: 2264594944 Enrollment ID: O20081216000739 |
News Archive
Standard treatment for prostate cancer can include chemotherapy that targets receptors on cancer cells. However, drug-resistant cancer cells can emerge during chemotherapy, limiting its effectiveness as a cancer-fighting agent. Researchers at the University of Missouri have proven that a compound initially developed as a cholesterol-fighting molecule not only halts the progression of prostate cancer, but also can kill cancerous cells.
In this digital age, where the internet accelerates technological development, there has been a surge of scientific innovation designed to improve the quality of life for patients in need.
Only one group of teenagers used marijuana more often after retail sales were legalized in Washington than they did before - high school seniors who work 11 or more hours per week, according to new research led by a WSU College of Nursing professor
"Having just returned to New York from Maputo, the capital of Mozambique, I'm reminded how lucky we are in this city to have reliable water and sanitation services," David Winder, chief executive of WaterAid USA, writes this post in Huffington Post's "Impact" blog.
Moffitt Cancer Center researchers developed a new way to identify possible therapeutic targets for patients with drug resistant melanoma. It involves using liquid chromatography-multiple reaction monitoring mass spectrometry to measure biomarkers or molecules in blood and tissue that indicates cancer is present. These measurements can help researchers determine if a patient is responding to treatment.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mrs Kaitlin Johnson, FNP 344 Great Rd, Acton, MA 01720-4004 Ph: (866) 528-7272 | Mrs Kaitlin Johnson, FNP 344 Great Rd, Acton, MA 01720-4004 Ph: (866) 389-2727 |
News Archive
Standard treatment for prostate cancer can include chemotherapy that targets receptors on cancer cells. However, drug-resistant cancer cells can emerge during chemotherapy, limiting its effectiveness as a cancer-fighting agent. Researchers at the University of Missouri have proven that a compound initially developed as a cholesterol-fighting molecule not only halts the progression of prostate cancer, but also can kill cancerous cells.
In this digital age, where the internet accelerates technological development, there has been a surge of scientific innovation designed to improve the quality of life for patients in need.
Only one group of teenagers used marijuana more often after retail sales were legalized in Washington than they did before - high school seniors who work 11 or more hours per week, according to new research led by a WSU College of Nursing professor
"Having just returned to New York from Maputo, the capital of Mozambique, I'm reminded how lucky we are in this city to have reliable water and sanitation services," David Winder, chief executive of WaterAid USA, writes this post in Huffington Post's "Impact" blog.
Moffitt Cancer Center researchers developed a new way to identify possible therapeutic targets for patients with drug resistant melanoma. It involves using liquid chromatography-multiple reaction monitoring mass spectrometry to measure biomarkers or molecules in blood and tissue that indicates cancer is present. These measurements can help researchers determine if a patient is responding to treatment.
› Verified 2 days ago
Nadia Tikhomirova, NP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 321 Main St, Acton, MA 01720 Phone: 978-635-8700 | |
Kristy P Smith, Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 321 Main St, Acton, MA 01720 Phone: 978-263-0680 | |
Ms. Tiffany Mcnamara, CNP-P Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 321 Main St, Acton, MA 01720 Phone: 978-635-8700 | |
Jill D Salamon, ARNP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 312 Nagog Hill Rd, Acton, MA 01720 Phone: 781-956-9467 | |
Christopher J Bechtel, NP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 321 Main St, Acton, MA 01720 Phone: 978-635-8700 Fax: 978-635-8921 | |
Ms. Kristie A Hadley, CNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 289 Great Rd, Acton, MA 01720 Phone: 978-679-1200 |